Disease management

Despite tightening barriers to entry over the years, Europe and the US are still key to global expansion for Korean startups, says Sky Labs CEO Jack Byunghwan Lee.

Also, digital gynaecology clinic Pinky Promise in India has raised $1 million in pre-seed funding.

Seoul National University Hospital researchers have developed an AI model that predicts the response to an anticonvulsant drug.

Private rheumatologist Dr Anandita Santosa in Singapore notes how current AI in healthcare priorities practically leave autoimmune and rheumatic diseases behind and shares what can be done to build a more comprehensive AI-driven preventive care ecosystem.

The company, which made the announcement at the JPM Healthcare Conference in San Francisco, will use the funds to expand its AI-powered Halo Intelligence platform.

AeviceMD says it has yet to conduct pilot deployments, which would focus on incorporating respiratory monitoring into outpatient asthma management pathways.

Tampa General Hospital Cancer Institute will integrate Reimagine's platform into its clinical pathways to reduce workforce burden and extend cancer care into the home.

The partnership comes three months after Thyme Care raised $97 million in funding, bringing its total raise to $275 million.

Respiree is also preparing to file for regulatory approval for its AI tool in the United States and across Australia, New Zealand, and Asia.

Screening rates in northern Queensland lag behind the statewide average.